Increased prolactin response to buspirone in chronic fatigue syndrome

Journal of Affective Disorders

Volumn 41, Issue 1, 1996, Pages 71-76

  Sharpe, M ^a   Clements, A ^a   Hawton, K ^a   Young, A H ^a   Sargent, P ^a   Cowen, P J ^a  

^a Univ Depts Psychiat Clin Neurol   (United Kingdom)

Author keywords

Buspirone; Chronic fatigue syndrome; Prolactin

Indexed keywords

BUSPIRONE; DOPAMINE; PROLACTIN;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030569317     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00075-4     Document Type: Article

References (25)

1. Acworth, I., Nicholass, J., Morgan, B. and Newsholme, E.A. (1986) Effect of sustained exercise on concentrations of plasma aromatic and branched-chain amino acids and brain amines. Biochem. Biophys. Res. Commun. 137, 149-153.
2. Anderson, I.M. and Cowen, P.J. (1992) Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology 106, 428-432.
3. Bailey, S.P., Davis, J.M. and Ahlborn, E N. (1993) Neuroendocrine and substrate response to altered brain 5-HT activity during prolonged exercise to fatigue. J. Appl. Physiol. 74, 3006.
4. Bakheit, A.M.O., Behan, P.O., Dinan, T.G., Gray, C.E. and O'Keane, V. (1992) Possible up-regulation of hypothalamic 5-hydroxytryptamine receptors in patients with post-viral fatigue syndrome. Br. Med. J. 304, 1010-1012.
5. Bearn, J., Allain, T., Cockeran, P., Munro, N., Butler, J., McGregor, A. and Wessely, S. (1995) Neuroendocrine response to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol. Psychiatry 37, 245-252.
6. Cleare, A.J., Bearn, J., Allain, T., McGregor, A., Wessely, S., Murray, R.M. and O'Keane, V.O. (1995) Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect. Disord. 35, 283-289.
7. Cowen, P.J. (1993) Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin. Neuropharmacol. 16 (Suppl. 3), S6-S18.
8. Dinan, T.G., Barry, S., Yatham, L.N., Mobyed, M. and O'Hanlon, M. (1990) The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle. Intern. Clin. Psychopharmacol. 5, 119-123.
9. Eison, A.E. and Temple, D.L. (1986) Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am. J. Med. 80 (Suppl. 3B), 1-9.
10. Ellis, P.M., Gartside, S.E., Ware, C.J., Campling, G.M. and Cowen, P.J. (1991) Does metergoline selectively attenuate 5-HT mediated prolactin release? Psychopharmacology 105, 129-131.
11. Goodall, E.M., Cowen, P.J., Franklin, M. and Silverstone, T. (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112, 461-466.
12. Gregory, C.A., Anderson, I.M. and Cowen, P.J. (1990) Metergoline abolishes the prolactin response to buspirone. Psychopharmacology 100, 283-284.
13. Maskall, D.D., Zis, A.P., Lam, R.W., Clark, C.M. and Kuan, A.J. (1995) Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol. Psychiatry 38, 235-239.
14. McMillen, B.A., Matthews, R.T., Sanghera, M.T., Shepard, P.D. and German, D.C. (1983) Dopamine receptor antagonism by the novel anti-anxiety drug buspirone. J. Neurosci. 3, 733-783.
15. Meltzer, H.Y., Gudelsky, G.A., Lowy M.T., Nash, J.F. and Koenig, J.I. (1991) Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms. In G. Tunnicliff, A.S. Eison, O.P. Taylor (Eds.), Buspirone: Mechanisms and Clinical Aspects. Academic Press, San Diego, CA, pp. 177-192.
16. Meltzer, H.Y. and Maes, M. (1994) Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Biol. Psychiatry 35. 316-323.
17. Moeller, F.G., Steinberg, J.L., Fulton, M., Kramer, G. and Petty, F. (1994) A preliminary neuroendocrine study with buspirone in major depression. Neuropsychopharmacology 10, 75-83.
18. Odontiadis, J. and Franklin, M. (1996) Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection. J. Pharm. Biomed. Anal., in press.
19. Park, S.B.G. and Cowen, P.J. (1995) Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118, 471-474.
20. Sharpe, M. (1996) Chronic fatigue syndrome. Psychiatr. Clin. N. Am. 19, 549-574.
21. Sharpe, M., Archard, L.C., Banatvala, J.E., Borysiewicz, L.K., Clare, A.W., David, A.S. et al. (1991) A report - Chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. 84, 118-121.
22. Vercoulen, J.H.M.M. Swanink, C.M.A., Zitman, F.G., Vreden, S.G.S., Hoofs, M.P.E., Fennis, J.F.M., Galama, J.M.D., van der Meer, J.W.M. and Bleijenberg, G. (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347, 858-861.
23. Willoughby, J.O., Menadue, M.F. and Liebelt, H. (1987) Activation of serotonin receptors in the medial basal hypothalamus stimulates growth hormone secretion in the unanethetized rat. Brain Res. 404, 319-322.
24. 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat. Neuroendocrinology 47, 83-87.
25. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders, 10th Edn. World Health Organization, Geneva.